Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Øjendyreklinikken ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   0.0% 11.3% 21.6% 12.1% 9.1% 8.7% 17.9% 17.9%   Credit score (0-100)   0 21 4 19 26 28 8 8   Credit rating   N/A BB B BB BB BB B B   Credit limit (kDKK)   0.0 0.0 -0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   0.0 -5.0 -68.0 1,273 1,653 1,917 0.0 0.0   EBITDA   0.0 -5.0 -68.0 254 494 632 0.0 0.0   EBIT   0.0 -5.0 -68.0 169 385 520 0.0 0.0   Pre-tax profit (PTP)   0.0 -9.0 -74.4 149.2 377.6 521.4 0.0 0.0   Net earnings   0.0 -7.0 -58.2 113.8 292.5 404.9 0.0 0.0   Pre-tax profit without non-rec. items   0.0 -9.0 -74.4 149 378 521 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 417 354 272 0.0 0.0   Shareholders equity total   0.0 33.0 -25.3 88.6 381 636 296 296   Interest-bearing liabilities   0.0 84.5 186 381 119 0.0 0.0 0.0   Balance sheet total (assets)   0.0 122 170 722 886 1,058 296 296   Net Debt   0.0 45.7 113 175 -163 -488 -296 -296     See the entire balance sheet 1000.0 Volume  2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   0.0 -5.0 -68.0 1,273 1,653 1,917 0.0 0.0   Gross profit growth   0.0% 0.0% -1,259.5% 0.0% 29.9% 16.0% -100.0% 0.0%   Employees   0 0 0 2 3 3 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 50.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   0 122 170 722 886 1,058 296 296   Balance sheet change%   0.0% 0.0% 38.7% 325.1% 22.7% 19.4% -72.0% 0.0%   Added value   0.0 -5.0 -68.0 253.9 469.7 631.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 332 -172 -194 -272 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   0.0 -1.0 -2.0 1.0 2.0 3.0 0.0 0.0   1000.0 Profitability  2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   0.0% 100.0% 100.0% 13.3% 23.3% 27.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   0.0% -4.1% -42.8% 36.8% 47.9% 53.7% 0.0% 0.0%   ROI %   0.0% -4.3% -44.7% 51.3% 78.8% 91.2% 0.0% 0.0%   ROE %   0.0% -21.4% -57.4% 88.1% 124.6% 79.6% 0.0% 0.0%   1000.0 Solidity  2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   0.0% 26.9% -13.0% 12.3% 43.0% 60.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   0.0% -913.3% -165.6% 69.0% -33.1% -77.3% 0.0% 0.0%   Gearing %   0.0% 256.5% -737.6% 429.9% 31.3% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 9.5% 4.8% 7.0% 2.9% 1.4% 0.0% 0.0%   1000.0 Liquidity  2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.0 0.6 12.0 0.4 0.7 1.4 0.0 0.0   Current Ratio   0.0 0.6 12.0 0.4 0.9 1.7 0.0 0.0   Cash and cash equivalent   0.0 38.9 73.9 205.6 282.8 488.2 0.0 0.0   1000.0 Capital use efficiency  2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   0.0 -32.4 95.9 -403.4 -38.9 284.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 127 157 211 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 127 165 211 0 0   EBIT / employee   0 0 0 84 128 173 0 0   Net earnings / employee   0 0 0 57 97 135 0 0